Trials / Completed
CompletedNCT07053579
Cross-cultural Adaptation and Validation of the P-CIN for Chinese Pediatric Oncology Patients
Cross-cultural Adaptation and Validation of the Pediatric Chemotherapy-induced Neuropathy (P-CIN) for Chinese Pediatric Oncology Patients: A Multi-center Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 313 (actual)
- Sponsor
- The Hong Kong Polytechnic University · Academic / Other
- Sex
- All
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study was to conduct a cross-cultural adaptation of the P-CIN into the Chinese context, assess its psychometric properties, and determine the cut-off value of CIPN among Chinese pediatric oncology patients. Participants provided demographic and clinical characteristics, and complete the translated P-CIN, Wong-baker FACES Pain Rating scale for pain, and Chinese version of the Pediatric Quality of Life Inventory (PedsQL) Cancer Module for quality of life.
Detailed description
A methodological, descriptive study was conducted.
Conditions
Timeline
- Start date
- 2025-01-05
- Primary completion
- 2025-05-30
- Completion
- 2025-05-30
- First posted
- 2025-07-08
- Last updated
- 2025-07-08
Locations
2 sites across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT07053579. Inclusion in this directory is not an endorsement.